What are Aurinia Pharmaceuticals's profit margins?

Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.

Where do Aurinia Pharmaceuticals's ratios come from?

Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Aurinia Pharmaceuticals AUPH Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	89.7%+1.5pp	88.5%+0.5pp	88.9%+1.7pp	89.5%+3.4pp	88.2%-0.5pp
Operating margin	41.7%+29.4pp	37.1%+39.1pp	26.3%+41.2pp	20%+49.3pp	12.3%+51.7pp
Net margin	100%+83.9pp	101.5%+99.0pp	29.3%+39.5pp	23.3%+47.6pp	16.1%+48.8pp
EBITDA margin	48.2%+28.1pp	43.9%+37.7pp	33.7%+40.5pp	27.5%+49.3pp	20.2%+52.4pp
Returns
Return on equity	65%+53.8pp	59.9%+58.4pp	20.7%+26.4pp	17.3%+30.6pp	11.2%+27.9pp
Return on assets	48.5%+40.7pp	44.1%+43.1pp	14.5%+18.5pp	11.8%+21.2pp	7.8%+20.7pp
Return on invested capital	25.2%+17.3pp	21.4%+22.5pp	16.7%+23.9pp	12.8%+27.0pp	7.9%+29.2pp
Efficiency
Asset turnover	0.5×0.0×	0.4×0.0×	0.5×+0.1×	0.5×+0.1×	0.5×+0.1×
Inventory turnover	0.7×0.0×	0.8×+0.1×	0.7×-0.1×	0.6×-0.2×	0.7×+0.1×
Liquidity
Current ratio	5.5×-0.4×	5.2×+0.7×	5.8×+0.2×	5.2×-0.1×	5.9×+0.3×
Quick ratio	5×-0.2×	4.8×+0.6×	5.2×+0.1×	4.6×-0.2×	5.3×+0.2×
Cash ratio	0.5×-0.5×	0.9×0.0×	1×+0.5×	0.7×+0.2×	1×+0.1×
Leverage
Debt-to-equity	0.2×-0.1×	0.2×-0.1×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Debt-to-assets	0.1×-0.1×	0.1×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	0.3×-0.2×	0.1×-0.6×	0.2×—	0.6×—	0.5×—
Interest coverage	29.1×+22.5×	24.2×+25.2×	15.8×+22.3×	11.5×+23.2×	6.6×+25.2×
Per Share
Book value per share	$4.12+68.6%	$4.19+62.3%	$2.69+1.0%	$2.44-3.6%	$2.45-2.0%
Valuation
Market capitalization	$1.97B+78.5%	$2.1B+63.6%	$1.45B+38.7%	$1.09B+33.2%	$1.1B+54.1%
Enterprise value	$2.01B+78.3%	$2.11B+63.1%	$1.48B+32.5%	$1.13B+28.2%	$1.13B+49.8%
Price / earnings	6.6×-21.1×	7.3×-216×	18.7×—	17.9×—	27.7×—
Price / sales	6.6×+2.1×	7.4×+2.0×	5.5×+0.7×	4.2×+0.2×	4.5×+0.7×
Price / book	3.5×+0.3×	3.6×+0.2×	4×+1.3×	3.2×+1.0×	3.2×+1.2×
EV / EBITDA	14×-8.7×	17×-70.8×	16.5×—	15.8×—	22.7×—
EV / sales	6.8×+2.2×	7.5×+2.0×	5.6×+0.5×	4.4×+0.1×	4.6×+0.6×
Earnings yield	15.1%+11.5pp	13.7%+13.2pp	5.4%+7.5pp	5.6%+11.7pp	3.6%+12.3pp
PEG ratio	0×—	0×—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Aurinia Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?: Aurinia Pharmaceuticals (AUPH) runs a 89.7% gross margin and a 41.7% operating margin, with a 100.0% net margin.
Where do Aurinia Pharmaceuticals's ratios come from?: Every ratio is computed from Aurinia Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.